Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2032

Conditions
Obsessive-Compulsive Disorder
Interventions
DEVICE

ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy

The ExAblate transcranial system combines a focused ultrasound surgery delivery system and a conventional diagnostic 3T MRI scanner. The ExAblate transcranial system provides real-time therapy planning algorithm, thermal dosimetry, and closed-loop therapy control.

Trial Locations (2)

94305

Stanford University, Palo Alto

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT06131502 - Sonication-based OCD Neurosurgical Intervention Via Capsulotomy | Biotech Hunter | Biotech Hunter